All Resources
Read all of the latest breakthroughs, insights, and news from Ginkgo.
BlogSeptember 17, 2024
Introducing Ginkgo’s Model API: A Programmable Interface for Ginkgo’s AI ResearchBlogSeptember 17, 2024
Request Free Inference Tokens for Ginkgo's Model APIBlogSeptember 17, 2024
AminoAcid-0 (AA-0): A Protein LLM Trained with 2 Billion Proprietary SequencesBlogDecember 19, 2023
FT011 - Hard, Bad, Bitter: Why I'm Hopeful about AI for BiologyBlogOctober 16, 2023
FT000 - About Foundry TheoryBlogSeptember 21, 2021
The End of the Beginning: Ginkgo Goes PublicBlogMay 14, 2021
Taking Ginkgo Public on NYSE:DNABlogMarch 18, 2021
Why Ginkgo Cares about Genetic PrivacyBlogDecember 8, 2020
Expanding Ginkgo's Platform for Biosecurity and Pandemic ResponsivenessBlogJune 18, 2020
Concentric by Ginkgo: COVID-19 testing at scaleBlogMay 4, 2020
How to Deploy Millions of COVID-19 Tests Per DayBlogApril 17, 2020
Teaming Up to Improve Antibody Therapeutics for COVID-19BlogApril 15, 2020
Supporting COVID-19 mRNA Vaccine Development with ModernaBlogApril 10, 2020
Project Update: COVID-19 DNA SynthesisBlogMarch 24, 2020
Scaling Up Whole Genome Sequencing of COVID-19BlogMarch 22, 2020
Synthetic Biology (and beyond) Community response to COVID-19BlogMarch 20, 2020
Fighting COVID-19 by Synthesizing DNABlogMarch 17, 2020
$25M of Free Platform Access for COVID-19 ProjectsBlogSeptember 16, 2019
Building a Platform for the Next Generation of Biotech StartupsBlogJune 26, 2018
Our Work on Biosecurity with IARPABlogMay 22, 2018
Why innovate with biology? Because you can’t eat softwareBlogOctober 3, 2017
1,000,000,000 Base Pairs of DNA